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Most of the articles, including ours, dealing with any 
application of ultrasound (US) in rheumatic diseases, 
start with a phrase that sounds like: “in recent years, US 
has gained a central role as an important tool for Rheu-
matologist clinical practice”. However, this is probably 
only the “sonographers” perception as currently US is 
not included in the diagnostic classification/criteria for 
the most important rheumatic diseases and also in many 
cases it is not recommended as the principal tool for the 
assessment and follow-up of patients. This is particularly 
relevant regarding rheumatoid arthritis (RA). 
Some recently published reviews [1] and the EULAR 
recommendations on the use of imaging for the clinical 
management of RA [2] have highlighted that current evi-
dence for the correct use of US for the monitoring of pa-
tients with RA is not strong enough to allow the definition 
of any recommendation on the use of US as a principal 
tool for this task. The point is that US has not clearly and 
unequivocally offered, in the very few available studies, 
any advantage over the use of clinical indices alone for 
this purpose. But how is this possible?
It is common knowledge and it has been very well 
demonstrated, that US is capable of revealing more syno-
vitis than a clinical examination in joints of patients af-
fected by RA as also acknowledged by  EULAR experts 
[2]. If this is true and if synovitis is the reason for joint 
damage progression, should US not be the most appro-
priate exam to predict joint damage? One of the papers 
that have tried to address the utility of US and clinical 
synovitis in predicting joint damage progression over a 
two year period  was  published in 2012 by Dougados 
et al [3]. In that study, 59 patients were assessed with 
US and clinical examination for synovitis at baseline and 
after a 4 month period and by conventional radiology 
at baseline and after 2 years for the evaluation of joint 
damage progression. The mean age of patients was 59 
years old (±12), prevalently overweight (BMI 25±5kg/
m2), females (81%), with a long standing disease (10±8 
years) and a relatively high percentage of surgery for RA 
(24% of patients). In this cohort of patients, joint dam-
age progression could be due to several reasons, for ex-
ample biomechanical modifications or the overloading 
of healthy joints, and the evaluation of joint space nar-
rowing as an outcome could be misleading regarding the 
ability of synovitis to predict joint damage independently 
of the method used to assess it. 
This is just an example of how difficult it could be to 
design a study that would address the fateful question: 
is US better than a clinical examination for patient fol-
low up? The perfect study should be carried out in young 
patients without other comorbidities, who do similar jobs 
(similar stress to the joints), who have no joint damage 
at the baseline, who are administered exactly the same 
treatment, who can be followed up for a sufficiently long 
period (years), who are always assessed  by the same as-
sessors for the whole period in a blind manner and many 
other aspects that are practically impossible to carry out 
in a real life study. This means that it would be really dif-
ficult to address this issue. But do we really need all this 
evidence?  Maybe we already have it!
Hippocrates, the father of Western Medicine, the one 
we currently practice, based his science on observations. 
He was the first to use a rectal speculum, an “endoscop-
ic” approach in the history of medicine and he was also 
the first thoracic surgeon to use lead pipes to drain chest 
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wall abscesses. He treated many patients and he spent 
his life observing and treating patients with the aim of 
categorising illnesses (acute, chronic, endemic and epi-
demic) and understanding their course coining phrases 
such as έξαρση (exacerbation), υποτροπή (relapse), 
κρίση (crisis), παροξυσμός (paroxysm), ανάρρωση (con-
valescence) and others still in use in modern medicine. In 
other words, since ancient times, doctors and researchers 
have been just trying to obtain one thing: information! 
And they were disposed to do their best in order to get it. 
In the 21st century, we practise the exact opposite phe-
nomenon. We are able to obtain such relevant information 
and in such an easy way but we are not ready to handle 
it! This is the case of US in rheumatology. With a simple, 
quick and harmless exam we can obtain all the necessary 
information and even more data on the status of the joint, 
tendons, periarticular tissues of patients with RA. We can 
make an accurate differential diagnosis, identifying with 
disarming precision, the site and the entity of the pathol-
ogy and also understand if a treatment works or not… by 
simply placing a probe on a joint. 
The rheumatologic scientific community is currently 
discussing whether US adds any advantages or not for 
the follow up of patients with RA with respect to clini-
cal examination alone. However, this is not the correct 
question to ask. The relevant point is: are all rheumatolo-
gists ready to use and handle all the information that US 
can provide? There is no answer to this question. What is 
crystal clear is that a clinical examination and US “see” 
different aspects of the same disease [4]. Maybe, if we re-
ally want to make some progress in this field, new studies 
should not be addressed to identify if US is more useful 
than clinimetric indices in RA, but only to understand 
what is or is not important from the enormous amount 
of information that US (and imaging generally) provides 
to the clinician. US captures many different aspects and 
probably not all of them have the same importance in a 
given moment of the disease in all patients. This is the 
real challenge for the future. To compare US to a clinical 
examination is like comparing a supercar to an old city 
car. Both of them can take you to your destination, but 
if you can correctly handle the supercar you will arrive 
quicker and safer; if not, you would be better using the 
old city car in order to avoid any potential accidents. 
It is clear that in modern medicine it is impossible to 
be an “expert” in many fields and from our point of view 
there is only one solution to this problem. Those of us 
who are willing to train, study and understand US should 
go ahead and continue or start to assess our patients using 
US. Those of us who are not, would be better continuing 
to use the old methods. US is just equipment; we should 
not expect it to take the place of the decision maker: the 
doctor! 
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